|
Volumn 149, Issue 19, 2005, Pages 1027-1032
|
Guideline 'delirium';Richtlijn 'delirium'
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BENZODIAZEPINE DERIVATIVE;
CHOLINERGIC RECEPTOR BLOCKING AGENT;
HALOPERIDOL;
HOMOCYSTEINE;
OPIATE;
PSYCHOTROPIC AGENT;
VITAMIN B GROUP;
ALCOHOL CONSUMPTION;
ALCOHOL WITHDRAWAL;
COGNITIVE DEFECT;
DAILY LIFE ACTIVITY;
DEHYDRATION;
DELIRIUM;
DIAGNOSTIC IMAGING;
DIFFUSE LEWY BODY DISEASE;
DISEASE PREDISPOSITION;
DISEASE SEVERITY;
DRUG CHOICE;
DRUG DEPENDENCE;
DRUG INDICATION;
ELECTROENCEPHALOGRAPHY;
ELECTROLYTE BLOOD LEVEL;
FEVER;
HUMAN;
INFECTION;
LABORATORY DIAGNOSIS;
MEDICAL SOCIETY;
MENTAL HEALTH;
NEUROLOGIC EXAMINATION;
PARKINSON DISEASE;
POLYPHARMACY;
PRACTICE GUIDELINE;
REVIEW;
SENSORY DYSFUNCTION;
AGED;
ANTIPSYCHOTIC AGENTS;
DELIRIUM;
DIAGNOSIS, DIFFERENTIAL;
GERIATRICS;
HUMANS;
NETHERLANDS;
PRACTICE GUIDELINES;
RISK FACTORS;
SOCIETIES, MEDICAL;
|
EID: 19944403256
PISSN: 00282162
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (28)
|
References (12)
|